Sientra Past Earnings Performance
Past criteria checks 0/6
Sientra has been growing earnings at an average annual rate of 11%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 8.1% per year.
Key information
11.0%
Earnings growth rate
35.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 8.1% |
| Return on equity | n/a |
| Net Margin | -65.7% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Fewer Investors Than Expected Jumping On Sientra, Inc. (NASDAQ:SIEN)
Apr 17
Sientra slides 18% on proposes stock offering
Oct 19Sientra refinances convertible debt at heavy premiums, sees Q3 revenue in-line
Oct 12Sientra gets regulatory nod to market breast implants in Saudi Arabia
Sep 20Sientra GAAP EPS of -$0.29 misses by $0.06, revenue of $21.5M misses by $2.26M
Aug 11FDA approves Sientra’s breast implant product for breast augmentation, reconstruction
Jul 06Sientra (NASDAQ:SIEN) Is Carrying A Fair Bit Of Debt
Apr 16Is Sientra (NASDAQ:SIEN) Using Too Much Debt?
Jan 06Revenue & Expenses BreakdownBeta
How Sientra makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 90 | -59 | 77 | 12 |
| 30 Jun 23 | 93 | -59 | 83 | 13 |
| 31 Mar 23 | 92 | -68 | 91 | 14 |
| 31 Dec 22 | 91 | -73 | 97 | 14 |
| 30 Sep 22 | 88 | -67 | 96 | 13 |
| 30 Jun 22 | 85 | -24 | 94 | 12 |
| 31 Mar 22 | 84 | -24 | 86 | 11 |
| 31 Dec 21 | 81 | -63 | 80 | 10 |
| 30 Sep 21 | 76 | -67 | 81 | 10 |
| 30 Jun 21 | 72 | -97 | 78 | 9 |
| 31 Mar 21 | 61 | -110 | 72 | 9 |
| 31 Dec 20 | 55 | -67 | 70 | 9 |
| 30 Sep 20 | 60 | -67 | 74 | 10 |
| 30 Jun 20 | 67 | -88 | 88 | 12 |
| 31 Mar 20 | 79 | -94 | 110 | 13 |
| 31 Dec 19 | 46 | -58 | 74 | 10 |
| 30 Sep 19 | 80 | -111 | 131 | 13 |
| 30 Jun 19 | 74 | -109 | 127 | 12 |
| 31 Mar 19 | 71 | -90 | 118 | 11 |
| 31 Dec 18 | 68 | -83 | 110 | 11 |
| 30 Sep 18 | 60 | -76 | 95 | 10 |
| 30 Jun 18 | 53 | -70 | 83 | 10 |
| 31 Mar 18 | 44 | -72 | 72 | 9 |
| 31 Dec 17 | 37 | -64 | 61 | 10 |
| 30 Sep 17 | 32 | -54 | 51 | 10 |
| 30 Jun 17 | 29 | -50 | 48 | 9 |
| 31 Mar 17 | 27 | -40 | 45 | 11 |
| 31 Dec 16 | 21 | -40 | 42 | 10 |
| 30 Sep 16 | 16 | -60 | 45 | 10 |
| 30 Jun 16 | 19 | -57 | 45 | 10 |
| 31 Mar 16 | 27 | -50 | 44 | 8 |
| 31 Dec 15 | 38 | -41 | 45 | 7 |
| 30 Sep 15 | 49 | -16 | 42 | 6 |
| 30 Jun 15 | 49 | -11 | 39 | 5 |
| 31 Mar 15 | 47 | -8 | 37 | 5 |
| 31 Dec 14 | 45 | -6 | 34 | 5 |
| 30 Sep 14 | 42 | -6 | 33 | 5 |
| 30 Jun 14 | 39 | -11 | 32 | 5 |
| 31 Mar 14 | 37 | -16 | 30 | 5 |
| 31 Dec 13 | 35 | -19 | 39 | 4 |
Quality Earnings: SIEN.Q is currently unprofitable.
Growing Profit Margin: SIEN.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SIEN.Q is unprofitable, but has reduced losses over the past 5 years at a rate of 11% per year.
Accelerating Growth: Unable to compare SIEN.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIEN.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: SIEN.Q's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.